Akhil Kapoor

1.3k total citations
154 papers, 683 citations indexed

About

Akhil Kapoor is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Akhil Kapoor has authored 154 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 62 papers in Pulmonary and Respiratory Medicine and 57 papers in Surgery. Recurrent topics in Akhil Kapoor's work include Lung Cancer Treatments and Mutations (26 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Akhil Kapoor is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Akhil Kapoor collaborates with scholars based in India, United States and United Kingdom. Akhil Kapoor's co-authors include Kumar Prabhash, Vanita Noronha, Mukesh Singhal, Satya Narayan, Amit Joshi, Nandini Menon, Vijay Patil, Abhishek Mahajan, Rajiv Kumar and Amit Janu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Akhil Kapoor

125 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akhil Kapoor India 14 340 240 193 115 97 154 683
Nazım Serdar Turhal Türkiye 15 369 1.1× 311 1.3× 181 0.9× 77 0.7× 99 1.0× 69 800
Atul Batra India 16 309 0.9× 192 0.8× 150 0.8× 125 1.1× 103 1.1× 122 881
Yüksel Ürün Türkiye 17 483 1.4× 334 1.4× 407 2.1× 127 1.1× 158 1.6× 136 1.1k
David E. Dawe Canada 15 212 0.6× 280 1.2× 110 0.6× 59 0.5× 93 1.0× 56 749
Seth A. Spector United States 15 124 0.4× 189 0.8× 238 1.2× 59 0.5× 53 0.5× 32 567
Deniz Tural Türkiye 17 478 1.4× 377 1.6× 217 1.1× 143 1.2× 116 1.2× 121 938
Alexandra Gangi United States 19 327 1.0× 151 0.6× 306 1.6× 225 2.0× 57 0.6× 67 863
Ozan Yazıcı Türkiye 14 328 1.0× 172 0.7× 105 0.5× 80 0.7× 121 1.2× 109 674
Mengyang Di United States 15 303 0.9× 127 0.5× 204 1.1× 78 0.7× 129 1.3× 54 770
Lucia Moletta Italy 14 474 1.4× 288 1.2× 330 1.7× 61 0.5× 74 0.8× 61 767

Countries citing papers authored by Akhil Kapoor

Since Specialization
Citations

This map shows the geographic impact of Akhil Kapoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhil Kapoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhil Kapoor more than expected).

Fields of papers citing papers by Akhil Kapoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akhil Kapoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhil Kapoor. The network helps show where Akhil Kapoor may publish in the future.

Co-authorship network of co-authors of Akhil Kapoor

This figure shows the co-authorship network connecting the top 25 collaborators of Akhil Kapoor. A scholar is included among the top collaborators of Akhil Kapoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhil Kapoor. Akhil Kapoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramaswamy, Anant, Prabhat Bhargava, S. Srinivas, et al.. (2024). Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial. Journal of Clinical Oncology. 42(27). 3218–3227. 1 indexed citations
2.
3.
Parikh, Purvish M., Akhil Kapoor, Tarini Prasad Sahoo, et al.. (2024). Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC). SHILAP Revista de lepidopterología. 14(1). 45–52. 1 indexed citations
4.
Kumar, Amit, Akhil Kapoor, Vanita Noronha, et al.. (2024). Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settings. PubMed. 2(1). 35–35. 1 indexed citations
5.
6.
Kashyap, Lakhan, et al.. (2023). Pattern of Care and Outcomes of Gallbladder Cancer Patients: Retrospective Study from a High Incidence Region in India. SHILAP Revista de lepidopterología. 12(3). 245–249.
7.
Ostwal, Vikas, Prabhat Bhargava, S. Srinivas, et al.. (2023). Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB). Journal of Clinical Oncology. 42(7). 800–807. 20 indexed citations
8.
Chandra, Manish, et al.. (2022). Qualitative and dosimetric assessment of radiation-induced xerostomia in patients with oral cancers treated with 3DCRT versus IMRT. Cancer Research Statistics and Treatment. 5(2). 232–239.
9.
Jain, Hasmukh, Akhil Kapoor, Manju Sengar, et al.. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 37(3). 379–385. 3 indexed citations
10.
Kapoor, Akhil, Vanita Noronha, Nandini Menon, et al.. (2021). Immune checkpoint inhibitors in patients with solid tumors and poor performance status. Medicine. 100(13). e25115–e25115. 6 indexed citations
11.
Kapoor, Akhil, Ashutosh Jain, Prabhat Bhargava, et al.. (2020). Chemotherapy-Induced Nausea and Vomiting in Gastrointestinal Cancer Patients: Do We Need to Revisit Guidelines?. South Asian Journal of Cancer. 9(4). 245–249. 1 indexed citations
12.
Kapoor, Akhil, Vanita Noronha, Vijay Patil, et al.. (2020). Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings. ecancermedicalscience. 14. 1038–1038. 9 indexed citations
13.
Gupta, Neelu, et al.. (2016). Role of Bone Marrow Aspiration and Biopsy in Diagnosis of Hematological Disorders: A Prospective Study. Journal of Pharmaceutical and Biomedical Sciences. 6(3). 2 indexed citations
14.
Yadav, Ajay, et al.. (2015). Gall bladder perforation: an unusual presentation of enteric fever.. Journal of Pharmaceutical and Biomedical Sciences. 5(5). 408–414. 1 indexed citations
15.
Kapoor, Akhil, et al.. (2014). Allele Frequency of ABO Blood Group Antigen and the Risk of Esophageal Cancer. BioMed Research International. 2014. 1–6. 11 indexed citations
16.
Kapoor, Akhil, et al.. (2014). Myoepithelioma of parotid: A case report and review of literature. SHILAP Revista de lepidopterología. 6(2). 53–53. 4 indexed citations
17.
Kapoor, Akhil, et al.. (2014). Sweet′s syndrome in accelerated chronic myelogenous leukemia: A case report and review of literature. Clinical Cancer Investigation Journal. 4(1). 112–112.
18.
Kapoor, Akhil, et al.. (2014). Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature. The Journal of Obstetrics and Gynecology of India. 65(3). 199–201. 3 indexed citations
19.
Kalwar, Ashok, et al.. (2013). Five Year Survival Analysis of Colon Cancer: A Retrospective Study. Journal of Gastroenterology and Hepatology Research. 2(12). 929–933. 1 indexed citations
20.
Gupta, et al.. (2002). Evaluation of panoramic radiography and axial computed tomography in cases of ameloblastoma and central giant cell granuloma of mandible.. PubMed. 12(4). 200–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nazım Serdar Turhal Breakdown of academic impact, for papers by Atul Batra Breakdown of academic impact, for papers by Yüksel Ürün Breakdown of academic impact, for papers by David E. Dawe Breakdown of academic impact, for papers by Seth A. Spector Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Alexandra Gangi Breakdown of academic impact, for papers by Ozan Yazıcı Breakdown of academic impact, for papers by Mengyang Di Breakdown of academic impact, for papers by Lucia Moletta
Rankless by CCL
2026